YAMAGAMI Hiroshi

Affiliation
Institute of Medicine
Official title
Professor
ORCID
0000-0001-8133-3314
Sex
Male
Birth date
1969-02
Research keywords
Cerebrovascular disease
Neuro-endovascular therapy
Antithrombotic therapy
Degree
2004-03博士(医学)大阪大学
Articles
Conference, etc.
  • 血圧管理で健康寿命を延ばす! ー降圧治療と脳卒中・認知症予防ー
    山上 宏
    茨城県Web研修会 かかりつけ医として知っておきたい最新の高血圧の知識/2026-02-24--2026-02-24
  • 急性期脳梗塞に対する再開通療法 ー何を目指すべきか?ー
    山上 宏
    第11回日本脳神経血管内治療学会近畿支部学術集会/2025-10-11--2025-10-11
  • Practice Regulatory Frameworks to Increase Timely Access to Thrombectomy In Japan and Beyond
    YAMAGAMI Hiroshi
    New Orleans/2026-02-04--2026-02-06
  • 会長講演
    山上 宏
    第41回日本脳神経血管内治療学会学術集会/2025-11-12--2025-11-15
  • Opning remarks
    YAMAGAMI Hiroshi
    第41回日本脳神経血管内治療学会学術集会/2025-11-12--2025-11-15
  • 無症候性内頚動脈・頭蓋内動脈狭窄に対する 血行再建術
    山上 宏
    第34回日本脳ドック学会総会/2025-06-27--2025-06-28
  • Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Atrial Fibrillation and Atherosclerosis
    YAMAGAMI Hiroshi
    The 5th Sun Yat-sen Brain Science Frontiers Interdisciplinary Forum/2025-09-12--2025-09-13
  • 急性期脳梗塞に対する血栓回収療法の適応と治療手技
    山上 宏
    第53回日本救急医学会総会・学術集会/2025-10-28--2025-10-30
  • 我が国におけるAIS診療体制の在り方とは?
    山上 宏
    日本脳神経外科学会第84回学術総会/2025-10-29--2025-11-1
  • When does Thrombectomy have Benefit in the Patients with Large Core Infarct
    YAMAGAMI Hiroshi
    48th ESNR Annual Meeting/2025-9-17--2025-9-21
  • 病院前脳卒中スケールと脳卒中の初期対応
    山上 宏
    第66回日本神経学会学術集会/2025-5-21--2025-5-24
  • Bleeding risk in patients with ischemic stroke and concurrent atrial fibrillation and atherosclerosis: Sub-analysis of ATIS-NVAF trial
    YAMAGAMI Hiroshi
    17th WORLD STROKE CONGRESS/2025-10-22--2025-10-24
  • Angiographic characteristics and champagne bottle neck sign in pediatric moyamoya disease.
    Tamura Goichiro; Muroi Ai; Ito Yoshiro; Hirata Koji; ...
    51th annual meeting of International Society of Pediatric Neurosurgery (ISPN2025)/2025-10-27--2025-10-30
  • Cerebral small vessel diseases in young adults with ischemic stroke receiving long-term antithrombotic therapy
    Miwa Kaori; Koga Masatoshi; Tanaka Kanta; Yoshimura S...
    American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium/2026-02-03--2026-02-03
  • Oral Anticoagulation With or Without Antiplatelet Therapy After Atherothrombotic Versus Cardioembolic Stroke in Patients With Nonvalvular Atrial Fibrillation and Atherosclerotic Cardiovascular Disease
    Shirakawa Manabu; Uchida Kazutaka; Sakakibara Fumihiro...
    American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium/2026-02-03--2026-02-03
  • Oral Anticoagulant Monotherapy vs Oral Anticoagulant Plus Antiplatelet Therapy in Paroxysmal and Persistent Atrial Fibrillation: A Prespecified Subanalysis of the ATIS-NVAF Trial
    Yamada Erika; Yoshimoto Takeshi; Maruo Kazushi; Okazak...
    American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium/2026-02-03--2026-02-03
  • Age Subgroup Analysis of Anticoagulant Monotherapy Versus Combination Therapy in Patients With Ischemic Stroke and Nonvalvular Atrial Fibrillation - ATIS-NVAF trial -
    Yoshimoto Takeshi; Yamada Erika; Maruo Kazushi; Okazak...
    American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium/2026-02-03--2026-02-03
  • Baseline Systolic Blood Pressure Modifies the Net Benefit of Combination Antithrombotic Therapy After Ischemic Stroke/TIA in Patients With NVAF and ASCVD: Subanalysis of the ATIS-NVAF trial
    Ikenouchi Hajime; Saito Takuya; Yazawa Yukako; Okazaki...
    American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium/2026-02-03--2026-02-03

(Last updated: 2026-08-10)